已收盤 05-15 16:00:00 美东时间
-0.240
-1.16%
今日重点评级关注:HC Wainwright & Co.:维持Artiva Biotherapeutics"买入"评级,目标价从15美元升至35美元;韦德布什:维持Cullinan Therapeutics"跑赢大市"评级,目标价从36美元升至37美元
05-11 15:43
Barclays analyst David Anderson downgrades NOV (NYSE:NOV) from Equal-Weight to Underweight and raises the price target from $20 to $21.
05-08 20:40
今日重点评级关注:HC Wainwright & Co.:维持Protara Therapeutics"买入"评级,目标价从23美元升至27美元;BTIG:维持Black Diamond Therapeutic"买入"评级,目标价从10美元升至11美元
04-30 19:24
Susquehanna analyst Charles Minervino maintains NOV (NYSE:NOV) with a Positive and raises the price target from $22 to $24.
04-29 21:45
NOV (NYSE:NOV) held its first-quarter earnings conference call on Tuesday. Belo...
04-29 05:11
华盛资讯4月29日讯,国民油井华高公布2026财年Q1业绩,公司Q1营收20.52亿美元,同比下降2.4%,归母净利润0.19亿美元,同比下滑74.0%。
04-29 02:02
华盛资讯4月28日讯,国民油井华高公布2026财年Q1业绩,公司Q1营收20.52亿美元,同比下降2.4%,归母净利润0.19亿美元,同比下滑74.0%。
04-28 21:19
Companies Reporting Before The Bell • Alliance Res Partners (NASDAQ:ARLP) is es...
04-27 19:11
NOV (NOV) is scheduled to announce Q1 earnings results on Monday, April 27th, after market close. The consensus EPS estimate is $0.15, and the consensus revenue estimate is $2.05B (-2.4% Y/Y). More on...
04-27 05:35
今日重点评级关注:Canaccord Genuity:维持Vertical Aerospace"买入"评级,目标价从9.5美元升至10.5美元;Canaccord Genuity:维持AtaiBeckley Inc."买入"评级,目标价从14美元升至15美元
04-21 11:25